The Lipoprotein(a) Paradox: Understanding the Clinical Failure of Pelacarsen in Cardiovascular Risk Reduction
"The failure of pelacarsen to reduce cardiovascular events suggests that lowering lipoprotein(a) may be akin to silencing a fire alarm rather than extinguishing the fire itself, challenging decades of assumptions…